Study Cases Clause Samples

Study Cases. The analysis summarized in this report used the power flow cases described below. When setting up the cases, tap settings of phase angle regulators and autotransformers were adjusted, within their capabilities, to regulate power flow and voltage. Similarly, switched shunt capacitors and reactors were switched were allowed to regulate voltage. Additionally, the Leeds SVC, ▇▇▇▇▇▇▇ SVC and ▇▇▇▇▇ FACTS device were held near zero output. The effectiveness of the SPS has been evaluated for summer peak load for two base system conditions described below. It is noted that ▇▇▇▇▇▇▇▇▇ has the lowest voltage in the base case with the SPS. The capacitor bank could be installed at ▇▇▇▇▇▇▇▇▇ or Sprain Brook but there are concerns that space may be limited in those two stations. Therefore, Millwood was chosen to be the installation location and the capacitor bank size was installed to maintain the steady-state pre-contingency voltage at the four stations above 348 kV while keeping the Athens generator scheduled voltage 1.04 pu as modeled in the Benchmark case without the SPS.
View SourceView Similar (6)
Study Cases. The analysis summarized in this report used the power flow cases described below. When setting up the cases, tap settings of phase angle regulators and autotransformers were adjusted, within their capabilities, to regulate power flow and voltage. Similarly, switched shunt capacitors and reactors were switched were allowed to regulate voltage. Additionally, the Leeds SVC, ▇▇▇▇▇▇▇ SVC and ▇▇▇▇▇ FACTS device were held near zero output. The effectiveness of the SPS has been evaluated for summer peak load for two base system conditions described below. Case 1 - Benchmark Case without the SPS. In this case, Athens was dispatched with two GT/CT sets on at a total power output of 700 MW. Case 2 - Case 1 with the SPS modeled. In this case, Athens was increased to its full capacity i.e., 1080 MW in three combine cycle trains to increase flow on the Athens-Pleasant Valley and Leeds-Pleasant Valley (Lines 91 and 92) path. Additionally, a 240 MVAr capacitor bank was added to maintain the voltages at the Pleasant Valley, Millwood, Sprain Brook and ▇▇▇▇▇▇▇▇▇ stations above below 348 kV (a recently updated pre-contingency low voltage limit for these stations). It is noted that ▇▇▇▇▇▇▇▇▇ has the lowest voltage in the base case with the SPS. The capacitor bank could be installed at ▇▇▇▇▇▇▇▇▇ or Sprain Brook but there are concerns that space may be limited in those two stations. Therefore, Millwood was chosen to be the installation location and the capacitor bank size was installed to maintain the steady-state pre-contingency voltage at the four stations above 348 kV while keeping the Athens generator scheduled voltage 1.04 pu as modeled in the Benchmark case without the SPS.
View Source

Related to Study Cases

  • Final Approval Hearing “Final Approval Hearing” shall mean the hearing at which the Court will consider and finally decide whether to enter the Final Judgment.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Competent Authorities The Parties shall inform each other about the structure, organisation and division of competences of their competent authorities during the first meeting of the Sanitary and Phytosanitary Sub-Committee referred to in Article 65 of this Agreement ("SPS Sub-Committee"). The Parties shall inform each other of any change of the structure, organisation and division of competences, including of the contact points, concerning such competent authorities.